|
1
|
Villa D, Jiang A, Crosbie N, Rule S, McCulloch R, Visco C, Buege MJ, Kumar A, Bond D, Paludo J, Maurer MJ, Thanarajasingam G, Baech J, El‐Galaly T, Kugathasan L, Gerrie AS, Lewis D. TIME TO SECOND LINE BRUTON TYROSINE KINASE THERAPY AND AGE AT ITS INITIATION ARE STRONGLY ASSOCIATED WITH SUBSEQUENT OVERALL SURVIVAL IN PATIENTS WITH FIRST RELAPSE OF MANTLE CELL LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.59_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- D. Villa
- BC Cancer, Centre for Lymphoid Cancer Vancouver Canada
| | - A. Jiang
- BC Cancer, Centre for Lymphoid Cancer Vancouver Canada
| | - N. Crosbie
- University Hospitals Plymouth NHS Trust Haematology Plymouth UK
| | - S. Rule
- University Hospitals Plymouth NHS Trust Haematology Plymouth UK
| | - R. McCulloch
- University Hospitals Plymouth NHS Trust Haematology Plymouth UK
| | - C. Visco
- University of Verona Hematology Verona Italy
| | - M. J. Buege
- Memorial Sloan Kettering Cancer Center Clinical Pharmacy, Lymphoma New York USA
| | - A. Kumar
- Memorial Sloan Kettering Cancer Center Division of Hematologic Malignancies New York USA
| | - D. Bond
- The Ohio State University Hematology Columbus USA
| | - J. Paludo
- Mayo Clinic Hematology Rochester USA
| | - M. J. Maurer
- Mayo Clinic Division of Clinical Trials and Biostatistics Rochester USA
| | | | - J. Baech
- Aalborg University Hospital Haematology Aalborg Denmark
| | - T. El‐Galaly
- Aalborg University Hospital Haematology Aalborg Denmark
| | - L. Kugathasan
- BC Cancer, Centre for Lymphoid Cancer Vancouver Canada
| | - A. S. Gerrie
- BC Cancer, Centre for Lymphoid Cancer Vancouver Canada
| | - D. Lewis
- University Hospitals Plymouth NHS Trust Haematology Plymouth UK
| |
Collapse
|